Pfizer, Novartis, Sanofi, AstraZeneca — global pharma giants are no longer just outsourcing to India. They’re building from India. The rise of Pharma GCCs (Global Capability Centers) is turning India into the brain of the pharmaceutical world.
In this video, we uncover how cities like Bengaluru and Hyderabad have quietly become global hubs for drug discovery, AI-led clinical trials, regulatory science, and precision medicine. With 36+ pharma GCCs and counting, this isn’t support work — it’s frontline innovation.
From Pfizer’s AI analytics hub in Mumbai to Novartis running clinical operations for 140 countries from Hyderabad, we dive into how India’s talent, infrastructure, and policy are powering a pharma gold rush. And with US tariff exemptions, billion-dollar investments, and 50,000+ jobs being created — the world is waking up to India’s pharma power.
This is more than a business story. It’s a strategic shift — one that could change how fast new drugs reach the world.
India’s Biggest AI Summit & Expo from the Heart of Bengaluru:
Subscribe to AIMTv for deep dives into AI, tech, pharma, and the forces shaping our future.
Read our latest stories:
Watch more videos:
#pharma #gcc #pharmagcc #indiapharma #clinicaltrials #drugdiscovery #bengaluru #hyderabad #aimtv #globalpharma #life_sciences #sanofi #novartis #astrazeneca #pharmainnovation #healthtech
source
